Pliant Therapeutics, Inc. (PLRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 13.25 |
| Open | 13.80 |
| Bid | 13.94 x 500 |
| Ask | 14.01 x 400 |
| Day's range | 13.58 - 14.09 |
| 52-week range | 11.21 - 24.74 |
| Volume | |
| Avg. volume | 378,682 |
| Market cap | 843.255M |
| Beta (5Y monthly) | 1.12 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Earnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
Pliant Therapeutics, Inc. (PLRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GuruFocus.com
Pliant Therapeutics Inc CFO Keith Cummings Sells 9,781 Shares
Keith Cummings, the CFO of Pliant Therapeutics Inc, sold 9,781 shares of the company on January 17, 2024, according to a recent SEC filing.
- Zacks
Is a Surprise Coming for Pliant Therapeutics (PLRX) This Earnings Season?
Pliant Therapeutics (PLRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2024 Yahoo. All rights reserved.